Pharmaceutical Contract Drug Interaction Testing Services

Drug-drug interactions (DDIs) may occur when taking two (or more) drugs together results in altered efficacy or behavior of one or both drugs, potentially causing adverse effects. As drug developers move promising candidates through the development pipeline, evaluating DDIs potential is a critical component of safety testing. These studies are typically guided by recommendations published by regulatory authorities, which underline the utility of in vitro experiments to predict in vivo observations, justify decisions, and inform clinical study design.